Search

Citatuzumab Bogatox

VB6-845 is a humanized antibody fragment targeting EpCAM fused with the deimmunized form of the cytotoxin Bouganin and is designed for systemic use against metastatic cancer. … VB6-845 has demonstrated effective cancer cell killing properties in pre-clinical tests.

Rhodamine B

Patupilone

Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol.

Vercirnon

Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. … It is under investigation in clinical trial NCT01611805 (Japanese Phase I of GSK1605786).

Indisulam

COVID-19 convalescent plasma

), and use for single patients through an emergency IND (eIND; 21 CFR 312.310). … COVID-19 patients is safe.

Pucotenlimab

[A257296] It is being investigated in other cancers. … Pucotenlimab is a recombinant humanized anti-PD-1 monoclonal antibody. It received its first global approval in China in July 2022 for the treatment of solid tumours.

Tezacitabine

A synthetic purine nucleoside analogue with potential antineoplastic activity.

Fosfructose

Glyphosate